New review examines complication rates in preventive breast surgery
NCT ID NCT04447339
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study reviews medical records of 75 women who had a preventive nipple-sparing mastectomy (removing breast tissue while keeping the nipple). The goal is to see how often complications occur within 42 days after surgery. Researchers also check if the surgery successfully removes all breast tissue while preserving the nipple. This is an observational study, not a test of a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 75 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2020
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Consecutive subjects that have undergone open NSM procedures for prophylaxis between January 1 2018 through 42 days prior to IRB approval will be included in this retrospective chart review.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: All female patients that have undergone open prophylactic NSM cases performed between January 1, 2018 through 42 days prior to IRB approval Exclusion Criteria: \-
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Nipple sparing mastectomy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic Hosp - Methodist Campus - MN
Rochester, Minnesota, 55905, United States
-
NorthShore University Health System
Evanston, Illinois, 60201, United States
-
Northwell Health
Queens, New York, 11040, United States
-
Pennsylvania Hospital
Philadelphia, Pennsylvania, 19107, United States
-
Univ. of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.